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In mammals, sexual hormones such as estrogens play an essential role in maintaining brain
homeostasis and function. Estrogen deficit in the brain induces many undesirable
symptoms such as learning and memory impairment, sleep and mood disorders, hot
flushes, and fatigue. These symptoms are frequent in women who reached menopausal
age or have had ovariectomy and in men and women subjected to anti-estrogen therapy.
Hormone replacement therapy alleviates menopause symptoms; however, it can increase
cardiovascular and cancer diseases. In the search for therapeutic alternatives, medicinal
plants and specific synthetic and natural molecules with estrogenic effects have attracted
widespread attention between the public and the scientific community. Various plants have
been used for centuries to alleviate menstrual and menopause symptoms, such as
Cranberry, Ginger, Hops, Milk Thistle, Red clover, Salvia officinalis, Soy, Black cohosh,
Turnera diffusa, Ushuva, and Vitex. This review aims to highlight current evidence about
estrogenic medicinal plants and their pharmacological effects on cognitive deficits induced
by estrogen deficiency during menopause and aging.
Keywords: Alzheimer’s disease, Parkinson’s disease, estrogenic plants, neurodegeneration, neuroprotection,
menopause, cognitive impairment
INTRODUCTION
Sex hormones such as androgens and estrogens significantly influence behavior (Hamson et al., 2016)
and support learning and memory (Andreano and Cahill, 2009; Munro et al., 2012; Colciago et al.,
2015; Kerschbaum et al., 2017). The effects of sex hormones on cognitionmay explain the differences in
cognitive abilities among sexes. For example, typically, women have superior verbal memory and are
better at recalling and associating words from a spoken list than men (Munro et al., 2012).
Experimental and epidemiological studies suggest that female sex hormones are neuroprotective,
preventing cognitive decline during aging. The discovery that brain regions involved in learning and
memory, such as the hippocampus and prefrontal cortex, differed in structure and function between
sexes suggested that sex hormones played a role in cognition (Kapur et al., 1995; Gasbarri et al., 2012;
Pompili et al., 2012). Sex hormones influence aging (Boss et al., 2014) and the incidence, progression,
and severity of symptoms in psychiatric disorders (Xing et al., 2013). One interesting potential
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beneficial effect of estrogens in the brain is to prevent the
deterioration of cognitive abilities during aging. Likewise,
estrogenic compounds’ study revealed a central role of the
cerebral estrogen receptors (ER)α and ERβ signaling on
cognitive abilities (Baez-Jurado et al., 2019). These receptors
have differential expression in the body’s tissues and cells.
They can have selective effects on different tissues. Most
phytoestrogens are full ERβ agonists and weak ligands of the
ERα (Gencel et al., 2012; Martinkovich et al., 2014). Estrogenic
compounds support cognitive abilities by a mechanism involving
the ERα (Tang S.-S. et al., 2018; Mitchnick et al., 2019). This
receptor, acting as a transcription factor, controls gene expression
in brain regions playing a vital role in learning and memory, such
as the hippocampus (Spencer-Segal et al., 2012; Frick et al., 2018;
Tang et al., 2019). Also, ERs promote neuroregeneration after
traumatic brain injury by stimulating astrocytes’ neuroprotective
effects (Martin-Jimenez et al., 2019).
There is abundant evidence on the therapeutic impact of
estrogenic compounds and the molecular mechanisms
underlying their beneficial effects diminishing inflammation,
oxidative stress, and neuronal loss after menopause. These
benefits may also account for their positive impact alleviating
the cognitive deficits in animal models of two leading types of
dementia; Alzheimer’s disease (AD) and Parkinson’s disease (PD)
(Figure 1). Tibolone (7-α, 17- α-17-hydroxy-7-methyl-19-
norpregn-5 [10]-en-20-ψn-3-one) an estrogenic synthetic drug
used as Hormone replacement therapy (HRT), is neuroprotective
against the neurotoxic effects of palmitic acid in the brain by
protecting astrocytes from inflammation by a mechanism
involving the ERβ In experimental models of inflammation
induced by a high-fat diet (González-Giraldo et al., 2018;
Hidalgo-Lanussa et al., 2018; González-Giraldo et al., 2019;
Martin-Jimenez et al., 2019; Hidalgo-Lanussa et al., 2020). On
the other hand, the phytoestrogens, also called natural selective
estrogen receptor modulators (SERMs), act as agonists or
antagonists for ERs. They have different effects on different
tissues and cells. The phytoestrogens have structural similarity
with 17-β estradiol, showing both agonist and antagonist effects
on the ERα and ERβ (Rietjens et al., 2017).
A comprehensive review of pertinent published literature on
estrogenic plants using the scientific databases SCOPUS, PubMed,
and Science Direct was done. The revision emphasized plants and
compounds with beneficial effects against oxidative stress,
inflammation, cell viability, and memory loss in cell and in vivo
studies of AD and PD. Only plants with scientific evidence of




It is estimated that by 2030, the world population of menopausal
and postmenopausal women will be 1.2 billion (Borrelli and
FIGURE 1 | Mechanism of action of estrogenic plants to prevent neurodegeneration and memory loss and other symptoms in women after menopause.
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TABLE 1 | Traditional medicinal plants with estrogenic activity.
Scientific name Family Common name Extract/compound Model Effect References




Adenophora stricta Miq Campanulaceae Sha shen and
ladybells
Methanolic extract Recombinant yeast system EA Kim et al. (2008)
Anemarrhena
asphodeloides Bunge







OVX rat EA Liu et al. (2001)
Circosta et al.
(2006)
Artemisia vulgaris L Asteraceae Mugwort Eriodictyol and apigenin Saccharomyces cerevisiae
strain BJ3505
EA Lee et al. (1998)








endogenous ERα, and SK-
NBE cells transiently











Decoction MCF-7 cells Activation of ERE Gong et al.
(2016)
Elettaria cardamomum L Zingiberaceae Cardamon Methanolic extract MCF-7 breast cancer cells
using the E-Screen
bioassay
EA Real et al. (2015)





Cullen corylifolium (L.) Medik Fabaceae Bu gu zhi, cule Ethanolic extract Saccharomyces cerevisiae








Cynomoriaceae Hongo de Malta
and jopo de lobo
Ethanolic extract Recombinant yeast system EA Zhang et al.
(2005)
Curcuma aromatica Salisb Zingiberaceae Yu jin, wild
turmeric




Fabaceae Ye bian dou Methanolic extract Ishikawa cells EA Yoo et al. (2005)
Epimedium brevicornu
Maxim
Berberidaceae Yin yang huo,
horney goat weed
Ethanolic extract Recombinant yeast system EA Zhang et al.
(2005)






MCF-7 cells EA, binding to




Glycyrrhiza uralensis Fisch Fabaceae Gan cao, Chinese
liquorice
Ethanolic extract Recombinant yeast system EA Kang et al.
(2006)




Recombinant yeast system EA toward either




Humulus lupulus L Cannabaceae Hops, pi jiu hua Methanolic extract Ishikawa cells Competitive
binding to ERα
and ERβ
Liu et al. (2001)
Hylodesmum podocarpum
subsp. oxyphyllum (DC.)
H.Ohashi and R.R.Mill. syn.
Desmodium oxyphyllum




Methanolic extract Ishikawa cells EA Yoo et al. (2005)
Iris domestica (L.) Goldblatt








Fabaceae Ji yan cao,
Japanese clover
Methanolic extract Ishikawa cells EA (Yoo et al., 2005)





Methanolic extract Ishikawa cells EA Yoo et al. (2005)
(Continued on following page)
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TABLE 1 | (Continued) Traditional medicinal plants with estrogenic activity.
Scientific name Family Common name Extract/compound Model Effect References
Lycopus cavaleriei H. Lév.
syn. Lycopus ramosissimus




Recombinant yeast system EA Kim et al. (2008)
Kang et al.
(2006)
Maackia amurensis Rupr Fabaceae Amur maackia,
chao xian huai
Methanolic extract Ishikawa cells EA Yoo et al. (2005)
Maackia floribunda (Miq.)




Methanolic extract Ishikawa cells EA Yoo et al. (2005)











Panax ginseng C.A. Mey.
and Panax quinquefolius L




Methanolic extract Ishikawa cells Competitive
binding to ERα
and ERβ
Liu et al. (2001)
Phaseolus vulgaris L Fabaceae Green bean Red
kidney bean









Fabaceae Ge ma mu, kudzu
root








(2003), Yoo et al.
(2005)
Reynoutria japonica Houtt.
syn. Fallopia japonica and
Polygonum cuspidatum












Rheum palmatum L Polygonaceae Chinese rhubard,
zhang ye da
huang








Extract (flavonoids) Molecular docking EA (ERα and ERβ) Powers and
Setzer (2015)














Ethanolic extract Recombinant yeast system EA Zhang et al.
(2005)
Senna obtusifolia (L.) H.S.




Ethanolic extract Recombinant yeast system EA Zhang et al.
(2005)
Sophora flavescens Aiton Fabaceae Ku shen Ethanolic extract Recombinant yeast system
and Ishikawa cells
EA Kang et al.
(2006)
Yoo et al. (2005)











Turnera diffusa Willd Passifloraceae Damiana,
oreganillo,
mexican tea
Methanolic extract Yeast estrogen screen
(YES) assay
EA Zhao et al.
(2008)
Vitex agnus-castus L Lamiaceae Vitex, chaste tree,
chasteberry
Methanolic extract Ishikawa cells Competitive
binding to ERα
and ERβ
Liu et al. (2001),
Liu et al. (2004)
(Continued on following page)
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Ernst, 2008). A systematic review of the literature and random-
effect meta-analyses of several clinical studies showed that
surgical menopause at any age was associated with a decline in
verbal and semantic memory and information processing
speed (Georgakis et al., 2019). As discussed in previous
reports, the role of estrogen over cognition became more
relevant due to the worldwide increase in female life
expectancy.
Different ER ligands, including phytoestrogens and
synthetic compounds such as tibolone, are under
investigation to alleviate or prevent these cognitive deficits.
Tibolone has many beneficial effects on the central nervous
system (Pinto-Almazan et al., 2017) by mechanisms
counteracting the effects of neuroinflammation, oxidative
stress, and mitochondrial dysfunction induced by different
insults acting on glial cells, including microglia and astrocytes
(González-Giraldo et al., 2018; Hidalgo-Lanussa et al., 2018;
González-Giraldo et al., 2019; Martin-Jimenez et al., 2019;
Osorio et al., 2019; Hidalgo-Lanussa et al., 2020) Tibolone
binds to the ERs and has positive effects diminishing the
negative consequences of estrogen deficiency on cognition
in ovariectomized (OVX) Sprague–Dawley rats by a
mechanism involving the enhancement of both the
serotoninergic and cholinergic systems (Espinosa-Raya
et al., 2012; Pinto-Almazan et al., 2017).
Clinical studies: Considering that menopause arrives on
average at 50 years of age, women without intervention can
spend more than 30 years in a hypoestrogenic state with
several global consequences on cognition and mood (Slaven
and Lee, 1997; Shilling et al., 2001). Sex hormones modulate
brain plasticity processes involved in high-order cognitive
functions such as learning and memory (Frick, 2009;
Henderson and Popat, 2011; Frick, 2012; Pompili et al., 2012;
Hamson et al., 2016; Korol and Wang, 2018). Clinical studies
investigated the correlation between the adult levels of sex
hormones and the documented differences in spatial and
verbal memory abilities among male and female subjects
(Hugdahl et al., 2006).
HRT with estrogens and progestins reduces postmenopausal
symptoms but increases the risk of mammary carcinomas and
cardiovascular events. For this reason, plant-derived estrogenic
compounds mimicking the effect of sex hormones with a better
safety profile are highly regarded (Wuttke and Seidlova-Wuttke,
2014).
Although no consensus has been reached (Kocoska-Maras
et al., 2011), most clinical studies show that HRT improves
cognitive abilities in menopausal women (Sherwin and
Grigorova, 2011). One of these studies included 96 non-
menopausal control women, 60 women treated with HRT, 56
postmenopausal women, and 41 men. Participants were
requested to learn two-word lists. When they learned list 1,
they were given either a forget or a remember list 1 cue.
When participants had learned list 2 and finished an
interference task, they need to write down all items they
recalled. Data analysis revealed an effect of sex hormones on
learning abilities as follows. Remember-cued control women
recalled more list 1 items than HRT users, young men, and
postmenopausal women. In forget-cued women, salivary
progesterone correlated positively with the recall of items.
Salivary 17 β-estradiol did not correlate with the number of
recalled items from list one or two in either remember- or
forget-cued control women. However, salivary 17 beta-
estradiol correlated with item recall in remember-cued
postmenopausal women. They concluded that sex hormones
do not affect general verbal memory acquisition or
consolidation but modulated cue-specific learning and
memory recall (Kerschbaum et al., 2017). Another study
showed that HRT with estrogen plus progesterone improved
speed cognitive processing in women carrying the
Apolipoprotein E (APOE) polymorphisms epsilon (ε) 2/ε3,
and ε4. However, women receiving HRT but carrying e3/e3
alleles showed worse verbal memory scores in the Montreal
Cognitive Assessment test than control subjects (Bojar et al.,
2013). The study of the relationship between endogenous
levels of sex hormones (estradiol, estrone, progesterone, and
free testosterone) and cognitive abilities (verbal episodic
memory, executive functions) showed that progesterone
concentrations positively correlated with verbal memory
and global cognition (Henderson et al., 2013). They also
found that the level of sex hormone-binding globulin
positively correlated with verbal memory performance
(Henderson et al., 2013).
TABLE 1 | (Continued) Traditional medicinal plants with estrogenic activity.
Scientific name Family Common name Extract/compound Model Effect References






MCF-7 cells EA binding to the





xanthioides (Wall ex Baker)





Methanolic extract Recombinant yeast system EA Kim et al. (2008)
Zingiber officinale Roscoe Zingiberaceae Jiang, ginger Methanolic extract Recombinant yeast system EA Kim et al. (2008)
Kang et al.
(2006)
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Various studies revealed that estrogen and progesterone
positively influence verbal memory in females, and this and
other cognitive skills in postmenopausal women (Keenan
et al., 2001; Maki and Hogervorst, 2003; Hogervorst et al.,
2009; Brown, 2013; Doty et al., 2015; Pinto-Almazan et al.,
2017; Moradi et al., 2018). Nevertheless, clinical studies by
the Women’s Health Initiative showed that women who
initiated estrogen treatment alone or combined with
progestin at older ages (65–79 years of age) presented a
higher risk of cognitive decline and dementia (Rocca
et al., 2011). This discrepancy can be explained by the
window of opportunity hypothesis, suggesting that
estrogen’s effects will vary depending on age, cause, and
stage of menopause. It seems that in women, estrogen
treatment is neuroprotective when started early after
menopause (50–60 years of age). The authors recommend
that women younger than 51 years of age with premature
natural menopause should benefit from HRT (Rocca et al.,
2011). Based on this evidence, it is reasonable to postulate
that estrogen deficiency can be a crucial factor affecting
brain function after menopause.
ESTROGENIC PLANTS
Estrogenic plants have been used from ancient times to
diminish the symptoms of menopause, such as hot flushes,
cognitive impairment, and depression. The most commonly
used are the Black cohosh (Actaea racemosa L) (Wuttke et al.,
2014), Ginger (Zingiber officinale Roscoe), Hops (Humulus
lupulus L.), Milk thistle (Silybum marianum), golden root
(Rhodiola rosea L.), Red clover (Trifolium pratense L), Sage
(Salvia officinalis L), Soy (Glycine max L), Damiana (Turnera
diffusa Willd. ex Schult), Ushuva (Physalis peruviana L), and
vitex (Vitex agnus-castus L). However, many more have been
investigated (Table 1).
The positive effects of sex hormones on cognition
encouraged the study of phytoestrogens present in
medicinal plants to alleviate the cognitive deficits during
menopause. A modern study used molecular docking
investigated more than 500 phytochemicals from 17
herbal supplements sold in the United States to identify
potential estrogenic or anti-estrogens herbal compounds.
Each compound was docked with the known structures of
the ERα and ERβ. The results revealed numerous compounds
that strongly docked with the ER, including Echinacea, milk
thistle (Silybum marianum), GB, Sambucus nigra, chaste tree
(Vitex agnus-castus), fenugreek (Trigonella foenum-
graecum), Rhodiola rosea, Licorice (Glycyrrhiza glabra),
wild yam (Dioscorea villosa), black cohosh (Actaea
racemosa), muira puama (Ptychopetalum olacoides or P.
uncinatum), red clover (Trifolium pratense), damiana
(Turnera aphrodisiaca or T. diffusa), and dong quai
(Angelica sinensis). Also, some men’s herbal supplements
showed robust docking to the ER: GB, gotu kola (Centella
asiatica), muira puama (Ptychopetalum olacoides or P.
uncinatum), and Tribulus terrestris. The authors
concluded that almost all popular herbal supplements
contain phytochemical components that may bind and
modulate hER, causing unwanted effects (Powers and
Setzer, 2015).
Phytoestrogens
Phytoestrogens including flavonoids, isoflavonoids, stilbenes, lignans,
ginsenosides, tetrahydrofurandiol, chalcones, and coumestans, and
are commonly found in fruits and other parts of various medicinal
plants (Slavin and Lloyd, 2012). Various traditional plants to alleviate
the effects of menopause contain phytoestrogens (Lorand et al., 2010).
In addition to their use to counteract menopause symptoms (Rowe
and Baber, 2021), phytoestrogens for their antioxidant and anti-
inflammatory properties may have many other therapeutic uses
including being considered anti-cancer drugs (Ardito et al., 2018;
Basu and Maier, 2018; Petrine and Del Bianco-Borges, 2021),
regulators of cholesterol metabolism, hepatoprotective (Alipour
and Karimi-Sales, 2020) and cardioprotective compounds (Asokan
Shibu et al., 2017). These properties have a broad impact on human
health under normal and pathological states in aging, including
beneficial effects on cognitive abilities (Thaung Zaw et al., 2017;
Dominguez and Barbagallo, 2018; Hussain et al., 2018).
Phytoestrogens at low doses have little or no effects on climacteric
complaints, but they mimic estrogen effects at high doses.
Phytoestrogens display higher selectivity for specific ERs
permitting more organ-specific actions than estrogen. For
example, the flavonoids catechin, rutin, daidzein, luteolin,
naringenin, and genistein are present in powder extracts of
Lespedeza bicolor. In behavioral experiments, L. bicolor’s extracts
(25 and 50mg/kg) improved the cognitive impairment induced by
intracerebroventricular injection of Aβ25-35 in several cognitive tests,
including the novel object recognition. These plant extracts enhanced
the endogenous antioxidant system increasing the glutathione (GSH)
expression and inhibiting the hippocampus’s acetylcholinesterase
activities. Also, L. bicolor increased the expression of the brain-
derived neurotrophic factor (BDNF), and phospho-Akt,
extracellular signal-regulated kinase (ERK), and cAMP response
element (CRE) expression that is reduced in the hippocampus by
Aβ. In conclusion, L. bicolor exerts a memory-enhancing effect in an
Aβ-induced mouse model of AD-like pathology (Ko et al., 2019).
Phytoestrogen-primarily the isoflavones genistein, daidzein and
coumestrol, stemming from soy (Glycine max) or red clover
(Trifolium pratense)—were suggested to have the desired but not
the undesired effects of estrogens.
However, the results of the most recent placebo-controlled
studies question the beneficial effects of phytoestrogens.
Nevertheless, when taken at the time of puberty,
phytoestrogens seem to prevent mammary cancer in
adulthood (Seidlova-Wuttke et al., 2013).
ESTROGENIC PLANTS FOR MENOPAUSE
Astragalus mongholicus Bunge.
Astragalus mongholicus Bunge. (syn. Astragalus membranaceus)
(Fabaceae), commonly named Mongolian milk, is used as a
constituent of the traditional Chinese medicine (TCM) named
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Danggui Buxue Tang (DBT). DBT is an herbal decoction
containing A. mongholicus and Angelica sinensis roots (5:1
w/w) that is employed to diminish menopausal symptoms.
Interestingly, calycosin, the main flavonoid in A. mongholicus,
has a structure similar to β-estradiol. Based on this evidence,
Gong investigated DBT and Calycosin’s ability to activate the
estrogen-responsive element (ERE) in cultured MCF-7 cells
(Gong et al., 2016). DBT has an EA that can be enhanced
2–5 times by Calycosin that did not show EA by itself. A
derivative from DBT, the herbal recipe-RRF that is composed
of Radix Astragali (root of A. mongholicus), Radix Angelicae
sinensis (root of A. sinensis), and Folium Epimedii (leaves of
Epimedium brevicomum Maxim.). RRF has shown a remarkable
protective effect in OVX rats and represents a promising
candidate for treating perimenopausal disorders (Xie et al.,
2012). The experiments consisted of giving daily oral
treatments with vehicle (Sham and OVX group), RRF (141,
282, and 564 mg/kg), and conjugated equine estrogens
(0.1 mg/kg) for 16 weeks. They analyzed bone mineral density
(BMD) assay and oxidative stress. The results showed that
repeated administration of RRF attenuated osteoporosis by
elevating the BMD levels of the total body and arrest bone
trabeculae degradation. 3) RRF exposure decreased serum
levels of constituent MDA and increased endogenous
Superoxide dismutase (SOD) activity (Xie et al., 2012).
Cynomorium coccineum subsp.
songaricum (Rupr.) J.Léonard
Cynomorium coccineum subsp. songaricum (Rupr.) J.Léonard
(Cynomoriaceae) is a estrogenic medicinal plant is commonly
known as Hongo de malta, and Jopo de Lobo grows in
Mediterranean countries. Ethanolic C. coccineum has an
estrogenic RP of 1.78 × 10–4 (Zhang et al., 2005). Recent
studies reported that C. coccineum was antidepressant in
perimenopausal rats (Miao et al., 2017) and reduced memory
impairment in OVX rats (Tian et al., 2019). In this plant,
phytoestrogen- and phytoandrogen-like effects have been
detected (Wang et al., 2017; Tao et al., 2019) and various type
of compounds, including eight triterpenoids, six flavonoids, four
fatty acids, eight phenolic acids, one anthraquinone, one
nucleoside, and one sterol have been identified (Li X. et al., 2020).
Vitex agnus-castus L.
Vitex agnus-castus L. (Lamiaceae), also known as chaste-tree
berry, is used to treat menopause symptoms and menstrual
dysphoria. The estrogenic effect of extracts of chaste-tree berry
has been investigated using cultured cells (Liu et al., 2001; Liu
et al., 2004). These studies reported that methanol extracts of this
plant increased the mRNA expression of ERβ and PR in the ER +
hormone-dependent T47D: A18 cells (breast cancer cell line) and
Ishikawa cells (endometrial cancer cell line). The analysis of the
extracts using an ER binding bioassay revealed the presence of
linoleic acid, a lipid with presumed EA, in the fruits. Vitex agnus-
castus L (Liu et al., 2001; Liu et al., 2004). Chasteberry, like other
estrogenic plant, induced the expression of the estrogen-inducible
gene pS2 in the breast cancer cell line S30 (Liu et al., 2001).
Epimedium brevicornu Maxim.
Epimedium brevicornu Maxim. (Berberidaceae) is a TCM
commonly known as Horney goat weed. A study investigating
the effect of Ethanolic extract of E. brevicornu showed an EA (RP
 2.30 × 10–4) (Zhang et al., 2005). Besides, the investigation of
the effect of different plants of the TCM on BMD found that
treatment with extracts of E. brevicornu stimulated cyclic AMP
response element (CRE) and the expression of osteoblastic
markers such as Runx2 and Bmp4 in MC3T3-E1 cells
(Rebhun et al., 2019). Also, Astragalus onobrychis extracts
inhibited the Interleukin (IL)-1β-induced activation of the
nuclear factor kappa B (NFκB) and a mix of these plants
prevented the loss of BMD with efficacy comparable to
estradiol in OVX rats (Rebhun et al., 2019).
Glycine max (L.) Merr
Glycine max (L.) Merr (Fabaceae) generally identified as
soybean, contains several phenolic compounds with EA,
including biochanin A, genistein, daidzein, formononetin,
and glycitein. These compounds activate both the ERα and
ERβ and bind to the progesterone receptor (PR) and androgen
receptor (AR). For example, Biochanin A, daidzein, genistein,
and formononetin bind to the PR and AR at concentrations of
0.39–110 mM (Beck et al., 2003). A study showed that Soybean
extracts exhibited selectivity for the ERβ and induced a higher
cell proliferation level than estradiol (Boue et al., 2003). The
increase in cell proliferation was suppressed by the estrogen
antagonist, ICI 182,780, suggesting that the ER was involved
(Boue et al., 2003). A double-blind, randomized, placebo-
controlled, 12 weeks trial evaluated the effect of high-dose
isoflavones on quality of life (QOL), cognition, plasma levels
of lipoproteins, and androgens in postmenopausal women
attended at a tertiary care center in the United States
(Basaria et al., 2009). Ninety-three healthy, ambulatory, and
postmenopausal women (mean age 56 years) were randomly
assigned to receive soy protein (20g-160 mg of total
isoflavones) or taste-matched placebo (20 g whole-milk
protein), with 84 women (90%) completed the study. QOL
was judged by the Menopause-specific Quality of Life
(MENQOL) questionnaire. Total, free, and bioavailable
testosterone, gonadotropins, Sex Hormone Binding Globulin
(SHBG), and fasting lipids were measured. The study found
significant improvements in all QOL subscales (vasomotor,
psychosexual, physical, and sexual) among the women
treated with isoflavones, while no changes were seen in the
placebo group (Basaria et al., 2009). No significant changes in
cognition, serum androgens, or plasma lipids induced by
isoflavones were observed. Total testosterone and HDL levels
were significantly lower in the people treated with isoflavones
when compared to the placebo group. The timing of isoflavone
supplementation with regards to the onset of menopause
appears to be important. The authors concluded that high
doses of isoflavones are associated with improved QOL
among women at the early stages of menopause, indicating
that isoflavones as alternatives to estrogen therapy may be
useful and safe to relieve menopausal symptoms (Basaria
et al., 2009).
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Angelica sinensis (Oliv.)
Angelica sinensis (Oliv.) (Apiaceae) commonly known as Dong
quai, and it is one of the most used medicinal plants. It is
prescribed for gastrointestinal, vascular, mental, and
gynecological disorders (Giacomelli et al., 2017). The
primary components identified in the plant extracts, Ferulic
acid, Z-Ligustilide, and polysaccharides, showed weak ER
binding and pS2 mRNA induction in the cells (Liu et al.,
2001). The administration of standardized ethanol extracts of
A. senensis to OVX rats stimulated the uterine
histoarchitecture, induced cornification of the vaginal
epithelium establishing an epidermal barrier, and reduced
luteinizing hormone (LH) concentration in serum.
Moreover, plant extracts’ administration provoked a
significant modification of the vaginal smear in 67% of
female control rats. Treated rats showed a prolonged estrus
stage with a transient interruption of their regular cyclicity
(Circosta et al., 2006). All this evidence suggests estrogenic
effects for this plant.
Rhodiola rosea L.
Rhodiola rosea L. (Crassulaceae) is also known as golden root,
rose root, roseroot, Aaron’s rod, Arctic root, king’s crown,
lignum rhodium, and orpin rosea. R. rosea has been
employed in Russia for a half-century, and ethanolic extract
of this plant (40% v/v) are used to relieve fatigue and increase
attention, memory, and work productivity. The typical dose
recommended is 5–40 drops 2–3 times a day, 15–30 min before
eating for 10–60 days. In Denmark, R. rosea is registered as a
botanical drug and widely used in Scandinavian countries to
increase cognitive abilities under stressful conditions. A
phytochemistry analysis of R. rosea has revealed six distinct
groups of compounds present in the root: Phenylpropanoids:
rosavin, rosin, rosarin (specific to R. rosea); Phenylethanol
derivatives: salidroside (rhodioloside), tyrosol; Flavonoids:
rodiolin, rodionin, rhodiosin, acetylrodalgin, tricin;
Monoterpernes: rosiridol, rosaridin; Triterpenes: daucosterol,
beta-sitosterol; Phenolic acids: chlorogenic and
hydroxycinnamic, and gallic acids (Elameen et al., 2010;
Elameen et al., 2020; Shikov et al., 2020). R. rosea is a
selective ER modulator, anti-inflammatory, and NFκB
inhibitor, as well as an inducer of the endothelial nitric oxide
synthase (NOS) that protects osteoblasts from hydrogen
peroxide toxicity (Gerbarg and Brown, 2016).
Anemarrhena asphodeloides Bunge
Anemarrhena asphodeloides Bunge (Asparagaceae), commonly
named zhi mu and rhizome, is native to China, Korea, and
Mongolia is a TCM. In Korea, A. asphodeloides B is employed as
antipyretic, diuretic, sedative, and antitussive medicine (Lee
et al., 2018). The study of ethanol extracts of A.
asphodeloides B revealed anti-osteoporotic effects, inhibiting
osteoclastogenesis and reducing inflammation (Kim et al.,
2017). Dichloromethane fractions of A. asphodeloides B
showed EA with a RP of 1.9 × 10–4 (RP of Estradiol (E2) was
1.0) (Kim et al., 2008). Methanolic extract (0.1 mg/ml) showed
moderate EA (Kang et al., 2006).
Salvia officinalis L.
Salvia officinalis L. (Lamiaceae), also known as sage, is one of the
most abundant species of Salvia (>500 species). These flowering
plants, native to the Mediterranean countries, have been used as
traditional medicines for centuries. S. officinalis contains phenolic
diterpenoids with antioxidants and anti-inflammatory activities
such as carnosic acid and carnosol (Abdellatif et al., 2020). S.
officinalis has EA and is used to control hot flashes. A study
investigating an aqueous-ethanolic extract of this plant
discovered EA in the ERLUX assay with an EC50  64 mg/ml
(Rahte et al., 2013). Fractionation of the EA in the extracts
revealed that luteolin-7-O-glucuronide (EC50  159 mg/ml)
was the active estrogenic compound. The authors concluded
that the positive effect of S. officinalis on hot flashes must be
due to the effect of estrogenic flavonoids present in Salvia (Rahte
et al., 2013).
Scutellaria baicalensis Georgi
Scutellaria baicalensis Georgi (Lamiaceae) is also known as
Baickal Skullcap and Huang Qin. An early study found that
ethanolic extracts of S. baicalensis have EA (RP of 8.77 × 10–5)
(Zhang et al., 2005). Additional studies have investigated S.
baicalensis alone or as part of herbal mixtures to treat health
conditions related to hormone dysregulation such as tumors
(Murashima et al., 2009), endometriosis (Ferella et al., 2018),
and prostate cancer (Hsieh and Wu, 2002). In a prostate cancer
study, LNCaP cells were treated with ethanol extracts of the
herbal mix PC-SPES or their components. Cells treated with PC-
SPES showed a 70–80% reduction in cell growth and viability. S.
baicalensis extracts halted cell growth by a 66.5% (Hsieh andWu,
2002).
Actaea racemosa L.
Actaea racemosa L. (syn. Cimicifuga racemosa (L.) Nutt.)
(Ranunculaceae) is also known as black cohosh. Extracts of
the rhizome of black cohosh have shown no having estrogenic
effects on mammary cancer cells in vitro and on mammary
gland and uterine histology in OVX rats. However, in those
rats, the extract A. racemosa L. BNO1055 reduced hot flushes
and the occurrence of osteoporosis (Seidlova-Wuttke et al.,
2003). Further reports from same author suggested that Actaea
racemosa L. extracts at low doses are adequate to ameliorate
climacteric complaints without adverse estrogenic effects
(Wuttke et al., 2014).
Clinical studies: In postmenopausal women, compared to
placebo Actaea racemosa L. BNO 1055 in a meaningful manner
reduced menopause symptoms similarly to conjugated
estrogens. Similar data were published for other European
Actaea racemosa L. preparations, whereas 2 US American
preparations were ineffective, most likely due to the doses
or purity of the preparations used. The European studies did
not report Actaea racemosa L. effects in the uterus nor
mammary glands.
A recent study evaluated the efficacy on climacteric problems
and safety of a combination of plant extracts (soy isoflavone,
black cohosh, chasteberry, and evening primrose oil extracts) in
post-menopausal women (Rattanatantikul et al., 2020). The study
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consisted of a randomized, double-blinded, placebo-controlled
trial. Post-menopausal women of 45–60 years old were randomly
assigned to either treatment (n  50) or placebo group (n  51).
Herb extracts and placebo were administered to participants, and
at baseline and after 6 and 12 weeks of treatments, symptoms of
menopause, endocrine profile, and blood chemistry were
assessed. Herbs’ combination significantly reduced hot flushes
and sweating, sleep problems, depressed mood, and irritability
symptoms compared with the placebo group. There were no
significant differences in hormonal levels between the test and
placebo groups; however, the C-reactive protein levels were found
significantly decreased. Moreover, serum LDL-C and triglyceride
levels were significantly lower than baseline levels in the
treatment group at 6- and 12 weeks timepoints. No adverse
effects were reported during the trial. These data indicate that
this combination of four medicinal herbs effectively and safely
improves menopausal symptoms, as well as general health
indicators, in post-menopausal women (Rattanatantikul et al.,
2020).
ESTROGENIC PLANTS AND COMPOUNDS
WITH POTENTIAL EFFECTS AGAINST
ALZHEIMER’S DISEASE
Some estrogenic plants have been investigated as therapeutic
tools to prevent memory loss after menopause and reducing the
risk of developing the most frequent neurodegenerative
conditions. AD is a neurodegenerative disease characterized by
cholinergic deficits, neuronal loss, glial dysfunction (Echeverria
et al., 2009), intracellular and extracellular accumulation of
aggregated forms of Aβ, and the appearance of intraneuronal
neurofibrillary tangles of hyperphosphorylated Tau in the brain
(McGeer, 1986; Mann, 1989; Masdeu et al., 2005). The main risk
factors involve traumatic brain injury (Gardner and Yaffe, 2015;
Daulatzai, 2017), posttraumatic stress disorder (PTSD) (Tsolaki
et al., 2009; Meziab et al., 2014; Ritchie et al., 2019), diabetes
(Chen and Zhong, 2013; Boccardi et al., 2019; Jash et al., 2020),
and age (Simpson et al., 2010; Bartzokis, 2011; Bove et al., 2014).
These abnormalities occur with neuroinflammation and
oxidative stress that orchestrate a cascade of events leading to
cognitive decline, gliosis, and synaptic loss. This idea is endorsed
by studies showing that inhibition of pro-inflammatory cascades
improves cognitive abilities in transgenic AD mice. Indeed, the
posttreatment of AD mice with the Raf inhibitor Sorafenib
inhibited the expression of several downstream inflammatory
factors such as NFkB and nitric oxide synthase (Echeverria et al.,
2009). Medicinal plants having anti-inflammatory effects can be
of use in preventing AD after menopause. Women are more
affected by AD, indicating that sex hormones are involved in the
disease progression (Vina and Lloret, 2010). Conditions affecting
estrogen production, such as premature ovarian insufficiency in
women less than 40 years of age, are associated with neurological
dysfunction and an increased risk of dementia (Soni and
Hogervorst, 2014).
Preclinical studies suggest a role for estrogenic compounds
preventing AD (Saunders-Pullman, 2003) (Morale et al., 2006)
(Morissette et al., 2008) (Siani et al., 2017) and other neurological
conditions (Hugdahl et al., 2006; Pompili et al., 2012). The
putative role of female hormones in the development of
dementia may explain the finding that women with a late
menopausal arrival (>53 years of age) have a decreased risk of
AD. It has been proposed that brain differences in the cholinergic
system among males and females may underlie the differences in
response to acetylcholinesterase inhibitors (AChEI) and the rate
of progression of AD between sexes, with a higher benefit of
AChEI treatment delaying the progression of the disease in men
than women (Giacobini and Pepeu, 2018). Estrogenic
compounds are neuroprotective against Aβ toxicity in vitro
(Svensson and Nordberg, 1999; Szego et al., 2011; Xing et al.,
2011; Bagheri et al., 2012; Wu et al., 2012; Napolitano et al., 2014;
Costa et al., 2016; Li et al., 2017; You et al., 2017; Yang et al., 2019)
as well as in vivomodels of AD (Bagheri et al., 2011; Limon et al.,
2012; Pompili et al., 2012; Zhao et al., 2013). In one of these
preclinical studies, to investigate the effect of estrogen on the
cholinergic deficit in AD, different Aβ assemblies were injected in
the nucleus basalis magnocellular (NBM) of sham control and
OVX mice, and the viability of cholinergic cells was measured
(Szego et al., 2011). The results showed that Aβ oligomers were
the most neurotoxic aggregated species and estrogen treatment
before Aβo infusion prevented cholinergic neuronal loss (Szego
et al., 2011). Furthermore, a proteomic analysis of the NBM
revealed significant differences among Aβ-treated mice and
control mice in the expression of the mitochondrial factors
DJ-1, NADH ubiquinone oxidoreductase, ATP synthase,
phosphatidyl-ethanolamine-binding protein 1, protein
phosphatase (PP) 2A, and dimethyl-arginine dimethyl-
aminohydrolase 1 (Szego et al., 2011). Besides, Aβ inhibited
MAPK signaling and stimulated NOS activity. The observed
increase in the activities of PP1 and PP2A may explain the
inhibition of MAPK signaling in the neocortex. Impressively,
pretreatment with estrogen prevented most of these proteome
changes (Szego et al., 2011). A few years ago, the role of the ERα, a
transcriptional factor involved in mitochondrial and energy
metabolism, was investigated in a transgenic (Tg) model of
AD expressing the amyloid β precursor protein (APP) and
presenilin 1 (PS1) containing familial AD (FAD) mutations
(Tg APP/PS1 mice). They found that the expression of the
ERα was progressively reduced in the brain of AD mice. More
importantly, HEK293 cells stably expressing the human APP, and
ERα showed reduced production of Aβ peptides, decreased Tau
phosphorylation, and reduced activity of a critical Tau kinase in
vivo, the glycogen synthase kinase 3β (GSK3β) (Tang Y. et al.,
2018). Coherent with the preclinical evidence, the results of
several clinical studies suggest that estrogen may prevent
cognitive decline and improve cognitive function in
postmenopausal women (Sherwin, 2012; Brown, 2013; Doty
et al., 2015). Estrogen or HRT would be an adequate
preventative treatment to reduce the risk of dementia in
women with a low risk of cardiovascular disease and a
heightened risk of developing dementia, For example, a person
with a family history of AD (Loucks and Berga, 2009). However,
some studies indicated that the effect of estrogen could also
depend on the age of the person treated as conjugated equine
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estrogens plus medroxyprogesterone acetate seems to augment
the risk of dementia in women over 65 years of age (Sano et al.,
2008; Maki and Henderson, 2012).
Medicinal plants have been used throughout the history of
humanity to improve mental abilities. The connection between
the estrogenic neuroprotective effect of medicinal plants and their
role against neurodegeneration has recently been investigated.
One of these investigations by Zhao et al. described a
phytoestrogen formulation named Phyto-β-SERM, which
exhibited a higher binding selectivity (83 times) for ERβ than
ERα. Phyto-β-SERM has central estrogenic neuroprotective
effects without inducing feminizing effects over the body.
Furthermore, chronic exposure to Phyto-β-SERM prevented
menopause symptoms in mice. Additionally, nine-month
treatment with Phyto-β-SERM prolonged survival improved
spatial recognition memory and reduced cerebral amyloid-β
plaque deposition in female triple-transgenic AD mice. A gene
expression analysis of AD mouse brains showed that
phytoestrogens were neuroprotective by a mechanism
involving the crosstalk between the ERβ and glycogen
synthase kinase 3 (GSK3β). This evidence supports the
therapeutic value of phytoestrogen for preventing AD
(Zhao et al., 2013). Various studies investigated whether
there were changes in estrogen/ERα expression on AD.
Since ERα gene expression is regulated by methylation
(Frick, 2015), a recent clinical study examined whether the
methylation level of the promoter of the ERα gene and its
protein expression correlated with changes in cognitive
function and quality of daily living in AD. The QOL of the
participants was tested with the QOL- AD scale and their
cognitive abilities were assessed using both the Mini-Mental
State Examination (MMSE) and the activities of daily living
(ADL) tests. The methylation status and level of expression of
the ERα gene were determined in the peripheral blood of 132
patients with AD and 135 healthy control subjects (Li et al.,
2019). This study showed that a higher level of methylation of
the ERα gene promoter correlated with a decreased ERα
expression and reduced cognitive abilities in AD patients
(Li et al., 2019). This evidence supports the view that lower
estrogenic signaling correlates with cognitive impairment in
AD. While most phytoestrogens act through ERα and ERβ,
some of their biological actions may also be mediated by other
effectors affecting these receptors’ signaling.
Kummerowia striata (Thunb.) Schindl.
Kummerowia striata (Thunb.) Schindl. (Fabaceae) is a flowering
plant generally named Japanese clover. The ethanolic extracts
have anti-inflammatory effects as tested in LPS-treated
RAW264.7 cells. In these cells, K striata downregulated the
expression of interleukin (IL)-1β, IL-6, NO, Tumour Necrosis
Factor alpha (TNF-α), cyclooxygenase 2 (COX-2), upregulated
IL-10 and the antioxidant factor heme oxygenase-1 (HO-1), and
inhibited the production of NFκB when compared to LPS treated
cells. This evidence suggests that the anti-inflammatory effects of
K. striata’s ethanol extract were due to the downregulation of IL-
1β, IL-6, nitric oxide, TNF-α, and COX-2 via the suppression of
NFκB activation and upregulation of IL-10 and HO-1. The
methanolic extracts of whole plant extracts of K. striata also
showed high EA with EC50 values of 7.7 μg/ml (Yoo et al., 2005).
Lespedeza bicolor Turcz
Lespedeza bicolor Turcz (Fabaceae) is a flowering plant known as
shrubby bush clover, bicolor lespedeza, and shrub lespedeza. L.
bicolor is broadly used in Australia, North America, and Eastern
Asia to reduce inflammation, nephritis, hyperpigmentation, and
diuresis (Ko et al., 2019). Catechin, genistein daidzein, luteolin,
naringenin, and rutin were identified in the powdered extract of L.
bicolor. The root extracts contain polyphenolic compounds that
delay prostate cancer progression (Dyshlovoy et al., 2020). Also, the
effects of L. bicolor on cognitive function were investigated in a
mice model of AD using a cerebral injection of Aβ. In this study,
analyzed in the following section, they identified Catechin, rutin,
daidzein, luteolin, naringenin, and genistein in the powdered
extract of L. bicolor. The methanolic extract of the stem of L.
bicolor showed high EA with EC50 values of 8.6 μg/ml (Yoo et al.,
2005).
Salvia lavandulaefolia Vahl.
Salvia lavandulaefoliaVahl. (Laminaceae), also known as Spanish
Sage, is originally from Spain and its extracts have anti-oxidant,
estrogenic, anti-inflammatory properties, and anti-butyryl and
anti-acetyl-cholinesterase activities (Kennedy and Scholey, 2006).
The essential oil and some of its monoterpenoid components
have acetylcholinesterase inhibitor (AChEI) activity. Antioxidant
activity was found in the ethanolic extract of the herb (5 mg/ml)
and the monoterpenoids (0.1 M) alpha- and beta-pinene and 1,8-
cineole. These ethanolic extracts (50 mg/ml) and alpha-pinene
and geraniol (0.2 mM), showed anti-inflammatory effects in vitro.
The essential oil of Spanish sage (0.01 mg/ml) and its
monoterpenoid component geraniol (0.1–2 mM) showed a
potential EA as evidenced by the induction of β-galactosidase
activity in yeast cells carrying a promoter stimulated by estrogenic
compounds (Perry et al., 2001). These properties can be useful in
AD, a condition characterized by a deficiency of the cholinergic
system, oxidative stress, and inflammation in the brain.
Elettaria cardamomum (L.) Maton
Elettaria cardamomum (L.) Maton (Zingiberaceae), also known
as Cardamom, is used to treat menstrual disorders in India
(Bhatia et al., 2015). A study tested the EA of E.
cardamomum, Plantago ovata seeds, and Gingko biloba (GBL)
and found that GBL and E. cardamomum seed extracts showed
both EA and anti-EA (Real et al., 2015). Interestingly, another
study showed that perinatal exposure to E. cardamomum extracts
positively affected learning and memory in mice (Abu-Taweel,
2018), suggesting that it may also be helpful in AD.
Glycyrrhiza uralensis Fisch.
Glycyrrhiza uralensis Fisch. (F. Fabaceae) is also known as
Chinese Liquorice, has potent EA. Screening of plant extracts
showed that G. uralensis induced a 300% increase in EA over
basal levels (Kang et al., 2006). In addition, Liquorice is used in
the Gegen Qinlian Decoction (GQD), a TCM prescribed to treat
diabetes mellitus. GQD is composed of Pueraria lobata (Willd.)
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Ohwi (gen), Scutellaria baicalensis Georgi (huang qin), Coptidis
chinensis Franch (huang lian), and Glycyrrhiza uralensis Fisch
(gan cao). GQD markedly decreased blood glucose and increased
serum insulin levels in type II diabetic mice (Xu et al., 2020). Since
diabetes is a risk factor for AD (Jash et al., 2020), this plant’s
extracts could be useful to diminish the risk of AD in persons
having a propensity to develop diabetes due to genetic
background (Jash et al., 2020).
Lycopus cavaleriei H.Lév.
Lycopus cavaleriei H.Lév. (syn. Lycopus ramosissimus (Makino)
Makino) (Lamiaceae) is an estrogenic plant that in Japan is
known as ko-shiro-ne, a term that means tiny white roots.
Dichloromethane extraction of L. cavaleriei yield extracts
showing EA with a RP to E2 of 0.8 × 10–4 (RP of E2 was 1.0)
(Kim et al., 2008). The methanolic extracts of other plant of the
same family, Lycopus lucidus Turcz. ex Benth. showed moderate
EA (Kang et al., 2006).
In a recent study, the inhibitory effect of three
phenylpropanoids isolated from L. lycidus, schizotenuin A, and
lycopic acids A and B-on Aβ fibrillization was investigated using
thioflavin-T assay and transmission electron microscopy (Sun
et al., 2020). These phenylpropanoids, containing three cathecol
groups, inhibited Aβ aggregation into amyloid plaques and the
authors suggested that the catechol moieties may be crucial in
reducing Aβ plaque formation (Sun et al., 2020).
A further study investigated the therapeutic potential of the
prenylflavonoid xanthohumol obtained from Humulus lupulus L
for AD in neuroblastoma N2a cells stably expressing human
Swedish mutant amyloid precursor protein (N2a/APP),
considered a cellular model of AD and HEK293/Tau cells,
showing tau hyperphosphorylation. The protein analysis
revealed that xanthohumol inhibited APP amyloidogenic
processing to Aβ the peptide acumulation, and decreased tau
hyperphosphorylation in the HEK293/Tau cells as well as in the
N2a/APP by promoting protein phosphatase 2 A PP2A, and
inhibiting GSK3β cells. Proteomic analysis by mass
spectrometry revealed 30 proteins differentially expressed in
the N2a/APP when compared to wild-type (WT) N2a cells
(N2a/WT), and a total of 21 differentially expressed proteins
in lysates of N2a/APP cells treated with xanthohumol. This
treatment reduced AD-like changes in the proteome of N2a/
APP cells, affecting proteins involved in endoplasmic reticulum
stress, cytoskeleton, oxidative stress, and proteasome
therapeutic potential of xanthohumol for treatment of AD
and/or other tauopathies (Huang et al., 2018). Colupulone, a
prenylated phloroglucinol obtained from Humulus lupulus,
activates the pregnane-X-receptor (PXR), a nuclear receptor
controlling the expression P-gp a protein that controls the
transport troghout the Blood-brain barrier (BBB). Various
colupulone analogs have been synthesized, and their effect on
Aβ uptake and transport has been evaluated. Among all tested
compounds, diprenylated acyl phloroglucinol displayed a
significant increase (29%) in Aβ transport across bEnd3 cells
grown on inserts as a BBB model. The results suggest the
potential of Colupulone to enhance the clearance of Aβ
across the BBB (Bharate et al., 2015).
Glycyrrhiza glabra L.
Glycyrrhiza glabra L. (Fabaceae), also named licorice, is a well-
known estrogenic plant (Zayed et al., 1964; Simons et al., 2011).
An evaluation of the EA in extracts of licorice showed only weak
ER and PR binding and estrogen-induced transcription of pS2
(presenilin-2), an estrogen-inducible gene present in S30 breast
cancer cells (Liu et al., 2001).
Other studies investigated the effect of Glabridin a compound
isolated from the roots of Glycyrrhiza glabra on cognitive
functions and cholinesterase activity in mice. Mice were
treated daily with Glabridin (1, 2 and 4 mg/kg.) for 3
consecutive days. The higher doses of glabridin significantly
reduced the amnesia induced by scopolamine (0.5 mg/kg) as
tested in the passive avoidance test. Furthermore, glabridin
remarkably reduced the brain cholinesterase activity in mice
compared to the control group. Based on the evidence they
postulated that glabridin could be a promising candidate for
treating memory impairment in AD patients (Cui et al., 2008).
Trifolium pratense L.
Trifolium pratense L. (Fabaceae) known as red clover contain
several polycyclic phenolic compounds, including biochanin A,
genistein, daidzein, formononetin, and glycitein. Biochanin A,
daidzein, genistein, and formononetin bound to the PR and AR in
the range of 0.39–110 mM (Beck et al., 2003). Compounds
isolated from methanolic extracts of red clover bound to the
ERα and ERβ and increased alkaline phosphatase activity and the
expression of PR in endometrial cells (Boue et al., 2003). Also, red
clover extracts upregulated estrogen-inducible gene presenelin-2
(pS2) in S30 cells. Isolation of estrogenic components in
fractionated extracts using liquid chromatography, mass
spectrometry, and an EA screening bioassay showed that the
isoflavone genistein was the most active phytoestrogen in the red
clover extracts (Liu et al., 2001).
Preclinical studies have shown that components isolated from
this estrogenic plant can be helpful in treating
neuroinflammation and cognitive disorders induced by a high-
fat diet in mice (Fu et al., 2019) and Aβ-induced cognitive deficits
in rats (Wei et al., 2015). In this latter study, they tested the
cognitive effects of an isoflavone isolated from T. pratense named
pretensein. Cognitive impairment was induced in the
experimental rats via bilateral injection of Aβ peptide into
their hippocampi. The results showed that treatment with
pratensein significantly decreased Aβ-induced cognitive
impairment and hippocampal neurodegeneration observed in
the vehicle-treated rats. Pratensein show anti-inflammatory
effects significantly decreasing inflammatory biomarkers such
as MDA, nitric oxide (NO), neuronal nitric oxide synthase
(nNOS), IL-1β and TNF-α. Pratensein also reduced Ab levels
by decreasing the expression of amyloid precursor protein (APP),
and the Aβ-synthetizing enzyme β-secretase (BACE1), cathepsin
B (CatB), neprilysin 2 (NEP-2), and the insulin-degrading
enzyme (IDE). Moreover, pratensein significantly increased the
expressions of synapse plasticity-related proteins, cAMP-
response element binding protein (CREB), the brain derived
neurotrophic factor (BDNF), Ca2+/calmodulin kinase II
(CaMKII), N-methyl-D-aspartate receptor 1 (NMDAR1),
Frontiers in Pharmacology | www.frontiersin.org May 2021 | Volume 12 | Article 64410311
Echeverria et al. Estrogenic Plants for Menopause
postsynaptic density protein 95 (PSD-95), protein kinase A beta
subunit (PKACβ), and protein kinase C gamma (PKCγ).
Furthermore, pratensein significantly decreased the activity of
acetylcholinesterase. The authors concluded that pratensein
represents an anti-AD active compound that enhances
synaptic plasticity and increases cholinesterase activity in the
brain (Wei et al., 2015).
Sophora flavescens Aiton
Sophora flavescens Aiton (Fabaceae) is commonly known as Ku
shen. Methanolic root extracts of S. flavescens induced a 400%
increase of EA in a yeast ER activity assay (Kang et al., 2006).
Similarly, methanolic extracts of whole plants showed high EA
(EC50 values of 3.2 μg/ml) (Yoo et al., 2005). In another study, the
ability of both Prenylflavonoids and lavandulyl flavonoids obtained
from the roots of S. flavescens, to displace 17 beta-estradiol (E2) from
rat uterine ER was investigated. The flavonoids investigated
included: 8-prenylkaempferol, leachianone A, maackiain,
norkurarinone, kushenol C, kushenol X. The results showed low
binding affinities of prenylated flavonoids; However, lavandulyl or
prenyl groups at position 8 enhanced their binding to rat uterine ER
(Hillerns and Wink, 2005). Anti-AD activities have been
characterized in compounds isolated from S. flavescens, such as
sophoflavescenol, a prenylated flavonol (Jung et al., 2011).
Prenylated flavonols from S. flavescens inhibit the generation of
advanced glycation endproducts (AGE), as well as BACE1 and the
ACh degrading cholinesterases (ChE). Isolation of the active
principles from S. flavescens by an activity-guided isolation
protocol permitted to identify compound sophoflavescenol
possessing high inhibitory activities against AGE, BACE1, andChEs.
Besides, another study reported noncompetitive BACE1
inhibitory effects of lavandulyl flavanones from S. flavescens.
Coherent with a BACE1 inhibition, these flavanones decreased
Aβ release by human embryonic kidney (HEK-293) cells (Hwang
et al., 2008).
Panax ginseng C.A. Meyer and Panax
quinquefolius L.
Panax ginseng C.A. Meyer and Panax quinquefolius L.
(Araliaceae) known as Asian ginseng and North American
ginseng, respectively. Intriguingly, extracts of P. ginseng and P.
quinquefolius increased the transcription of pS2 mRNA in S30
cells; however, no significant binding to the ER or induction of PR
expression was detected in the endometrial adenocarcinoma
Ishikawa cells that express both types of receptors (Liu et al.,
2001).
Many recent studies have shown its antioxidant and anti-
inflammatory effects of Ginseng in the brain affected by aging-
associated diseases and toxic insults such as sodium fluoride and
aluminum chloride (AlCl3) (Mahaboob Basha and Saumya, 2013;
Adam et al., 2019; Choi et al., 2021). One of these studies
investigated potencial pro-cognitive and neuroprotective effects
of compound K, a metabolite of ginsenosides, present in the
enzymatically hydrolyzed red ginseng extracts (HRGE). Amnesic
mice were treated with scopolamine and tested in the passive
avoidance Morris water maze and Y-maze tests. After euthanasia,
the mouse’s brains were dissected and analyzed for the expression
of antioxidant proteins analyzed by Western blot. The results
showed that oral HRGE (300 mg/kg body weight) reversed
learning and memory deficits in the scopolamine-treated mice.
In the hippocampus, HRGE upregulated the nuclear-factor-E2-
related factor 2 and its downstream antioxidant enzymes NAD(P)
H: quinone oxidoreductase and heme oxygenase-1(HO).
Treatment with HRGE also decreased glutamate excitotoxicity
and ROS levels in HT22 mouse hippocampal neuronal cells. The
authors proposed that HRGE alleviates cognitive impairment by
preventing neuronal apoptosis triggered by oxidative stress via
the upregulation of antioxidant factors such as HO (Ju et al.,
2021).
Coherent with its antioxidant effects, P . ginseng has proven to
be neuroprotective effects against Aβ toxicity in cellular and animal
models of AD-like neurodegeneration in rats treated with a
combination of D-Galactose and AlCl3. The results showed that
GP (10–100 μg/ml) increased neuronal survival the mRNA
expression of apoptotic proteins such as caspase-3 and Bax/Bcl-
2. Also, P. ginseng decreased Aβ and p-tau, iNOS, MDA, and NO,
and increased the cAMP levels, and the expression of SOD,
phospho-PKA and phospho-CREB. The authors concluded that
the neuroprotective effects of P . ginseng were due to the activation
of the cAMP/PKA/CREB pathway.
A preparation containing ginseng known as Jangwonhwan, a
boiled extract of 7 medicinal plants/mushrooms, including
Korean red ginseng, has been investigated. In a preclinical
study, 4.5 month-old transgenic (Tg)-APPswe/PS1dE9 AD
mice (Seo et al., 2010a; Seo et al., 2010b). In one of these
studies Tg mice were treated with a revised formula of
Jangwonhwan 300 mg/kg/day for 3 months. LMK02-
Jangwonhwan notably reduced Aβ1-42/1-40 levels, and plaque
deposition, in the brain of Tg-APPswe/PS1dE9 mice. LMK02-
Jangwonhwan moderately diminished oxidative stress and
prevented the down-regulation of phospho-CREB and
calbindin in the hippocampus. Also, when added to SH-SY5Y
neuroblastoma cells, Jangwonhwan inhibited oxidative stress and
Aβ-induced neurotoxicity (Seo et al., 2010b).
Rheum palmatum L.
Rheum palmatum L. (Polygonaceae), is a plant native to
southern Siberia and North and Central China. Commonly
known as rhubarb, and is used as traditional medicine
(Staglich, 1948). Ethanolic extracts of R. palmatum showed
an RP of 3.85 × 10–4 (Zhang et al., 2005). The screening of
different fractions of methanolic extracts for EA using the
recombinant yeast system, consisting of a hER expression
plasmid and a reporter plasmid, showed high EA levels
(EC50  0.093 mg/ml) in the dichloromethane fraction. An
activity-guided analysis of this fraction revealed five
anthraquinones: chrysophanol, physcion, emodin, aloe-
emodin, and rhein. Emodin showed the highest estrogenic
RP (6.3 × 10–2) to 17 b estradiol RP  1.0), and strong
cytotoxicity for ER (+) MCF-7 and ER (-) MDA-MB-231
breast cancer cells (Kang et al., 2008). Rhubarb also has
protective effects against Aβ toxicity in IMR-32 cells (Misiti
et al., 2006).
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ESTROGENIC COMPOUNDS EFFECTS ON
PARKINSON’S DISEASE
Parkinson’s disease (PD) is a neurodegenerative disease and the
second cause of dementia in the elderly. The physical
examination reveals resting tremor, bradykinesia/akinesia,
cogwheel rigidity, and gate impairment. The neuropathological
hallmarks of PD are the appearance of intracellular aggregated
forms of α-synuclein and the loss of dopaminergic neurons in the
midbrain (Iarkov et al., 2020). Because there are no effective long-
term treatments against PD, new therapeutic avenues are
intensely searched (Danielyan et al., 2011; Danielyan et al.,
2014; Jurado-Coronel et al., 2016; Mazo et al., 2017).
Some clues about potential new therapeutic avenues could
arise from the epidemiological studies showing a clear difference
in the PD incidence among sexes, with men being more affected
than women (Jurado-Coronel et al., 2018). Estrogenic hormones
such as estradiol seem to exert some protective effects against this
condition; unfortunately, in addition to its beneficial effects in the
brain, it may promote tumor growth in the ovary and breast. For
this reason, new ER modulators, or estrogen analogs with lower
activity on reproductive tissues, are being actively investigated as
preventative and curative drugs for PD (Hidalgo-Lanussa et al.,
2018).
Vicia faba L.
Vicia faba L. (Fabaceae) also known as broad bean is a plant of the
genus Vicia which members are considered to have many health
benefits against PD that are attributed to several biological
activities, including estrogenic, anticholinesterase,
antidepressant, antioxidant, anti-inflammatory and
antinociceptive, antidiabetic, anticoagulant, and antihypoxic
activities (Rabey et al., 1992; Apaydin et al., 2000; Raguthu
et al., 2009; Ramirez-Moreno et al., 2015; Abdel-Sattar et al.,
2021; Salehi et al., 2021).
Clinical studies: After discovering the deficiency o dopamine
in the striatum of patients with PD by Ehringer and
Hornykiewicz in 1960, and the motor improvement with
levodopa by Cotzias et al. in patients with PD, levodopa
became the gold standard for treating PD. Nevertheless, this
treatment resulted in motor fluctuations and dyskinesias in most
patients. Many years later, a clinical study showed that Broad
bean (Vicia faba)-a natural source of L-dopa-prolonged the "on"
periods in patients with PD who have "on-off" fluctuations and
shortened the “off (Apaydin et al., 2000). The study reported eight
patients that benefited from broad bean meals. The patients were
administered high doses of levodopa up to 800–1,000 mg per day,
benefits increasing “on” time without the appearance of
dyskinesias. One of the patients (Patient 1) showed a
persistent response, even when they ingested broad beans only
every other day. Astoundingly, in Patient 3, broad bean treatment
was accompanied by a decrease of dyskinesias and a reduction of
carbidopa/levodopa (L-DOPA) therapy. The authors considered
that broad bean’s effects are because the patients ingested their
broad bean meals garnished with yogurt rich in proteins. The
authors proposed that because amino acids from dietary proteins
compete with L-DOPA in crossing the BBB, they could reduce the
motor effects of L-DOPA. Unfortunately, this was an unblinded
trial, and a placebo effect cannot be discarded. A previous study
by Rabek et al. described the acute responses following a single
administration of broad beans to six patients with PD. They
reported an increase in plasma L-DOPA levels after broad
bean administration. This increase mirrored the motor
improvements achieved by single doses of carbidopa/
levodopa (Rabey et al., 1992). A similar rise of L-DOPA in
plasma induced by broad bean administration was described
by Vered et al. that reported that 40 g of freshly chopped
broad bean provided 120–130 mg of L-DOPA (Vered et al.,
1997).
Mucuna pruriens (L.) DC.
Mucuna pruriens (L.) DC. (Fabaceae) or velvet beans
(Atmagupta, Sanskrit) contain L-DOPA and have been used to
treat PD in India for many years (Vaidya et al., 1978; Manyam,
1990). Several animal studies in rodents (Dhanasekaran et al.,
2008) and monkeys (Lieu et al., 2012) have shown the beneficial
effects of M. pruriens against PD-like pathology. More
importantly, the therapeutic advantage compared to synthetic
L-DOPA is the reduced risk of developing dyskinesias (Lieu et al.,
2010).
One of the studies used a hemiparkinsonian rat model of PD to
compare the effects of chronic parenteral administration of a
water extract ofM. pruriens seed powder (MPE) alone, with MPE
combined with the peripheral dopa-decarboxylase inhibitor
benserazide (BZ), L-DOPA alone and L-DOPA + BZ. The
results were encouraging and chronic treatment with MPE
alone showed significant anti-parkinsonian effects without
causing dyskinesias (Lieu et al., 2010).
In a recent multicenter open trial in India, M. pruriens,
formulated as HP-200 (Manyam et al., 2004), was
administered orally to 60 patients with PD for 3 months. It
was extracted as a powder from the plant seeds and
administered mixed with water. The authors found that
consumption of dry seeds of broad beans did not experience
any clinical benefit. However, they found a significant
improvement of motor abilities in the patients treated with
HP-200, and hypothesized that this extract might contain





Estrogenic plants contain estrogenic compounds that, according
to many studies including from our research groups, have
antioxidant and anti-inflammatory activities that can be useful
in many conditions that characterize for inflammation and
oxidative stress, including neurodegenerative diseases as well
as other neurological conditions (Lanussa et al., 2016;
Hidalgo-Lanussa et al., 2018; Baez-Jurado et al., 2019;
González-Giraldo et al., 2019; Martin-Jimenez et al., 2019;
Vesga-Jimenez et al., 2019; Hidalgo-Lanussa et al., 2020).
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Zingiber officinale Roscoe
Zingiber officinale Roscoe (Zingiberaceae), commonly known as
ginger, is used as a food, spice, herbal supplement for its
antioxidant, anti-inflammatory and pharmacological activities
(Kiyama, 2020). Epidemiological studies indicated that Ginger
has beneficial effects on diabetes, metabolic syndrome,
hypercholesterolemia, and inflammatory disorders (Kiyama,
2020). Ginger components include monoterpenes (cineole,
citral, limonene, and alpha/beta-pinenes), sesquiterpenes (beta-
elemene, farnesene, and zerumbone), phenolics compounds
(gingerols, [6]-shogaol, [6]-paradol and zingerone), and
diarylheptanoids (curcumin). These compounds prevented cell
apoptosis, DNA damage, and inflammation by regulating cell
signaling, controlling autophagy and cellular metabolism.
Ginger-derived phytoestrogens are important bioactive active
components modulating essential brain functions. In a
previous study, ginger showed EA (RP of 3.7 × 10–1) (Kim
et al., 2008). A methanolic extract of the plant effectively
induced EA to more than 50% (Kang et al., 2006).
Achillea millefolium L.
An analysis of a raw extract of the aerial parts of Achillea
millefolium L. (Asteraceae) has EA when tested in MCF-7 cells
transiently expressing ERs. After fractionating the extract, they
found EA in a methanol/water fraction. From the phytoestrogens
present in this extract, apigenin and luteolin activated ERs, but
luteolin activated the ERβ but not the ERα (Innocenti et al., 2007).
Female rats treated with acetaminophen and aqueous extracts of
A. millefollium (2 g/kg/day) showed increased plasma levels of the
toxicity marker lactate dehydrogenase. However, the extracts
enhanced the activity of the antioxidant proteins reduced GSH
and glutathione S-transferase (GST) in the uterus (Baggio et al.,
2016). Furthermore, treatment with A. millefollium extracts
inhibited autoimmune encephalomyelitis in mice (Vazirinejad
et al., 2014).
A clinical study showed that A. millefolium extracts
(250–500 mg/day), when administered to 75 patients with
multiple sclerosis (MS) for a year, significantly delayed the
time to first relapse, reduced the number of lesions, and
improved their cognitive abilities (Ayoobi et al., 2019).
Reynoutria japonica Houtt.
Reynoutria japonica Houtt. (Polygonaceae), known as Huzhang in
China, is an herbaceous perennial plant natural to Eastern Asia,
China, and Russia. However, several species also find in Europe and
North America (Peng et al., 2013). Reynoutria japonica Houtt.
(Polygonaceae) has been used in clinical practice for the
treatment of cancer, endotoxic shock, favus, hyperlipemia,
infection, inflammation, jaundice, and scald in China and Japan
(Peng et al., 2013). More than 67 compounds, including quinones,
stilbenes, flavonoids, coumarins, and ligands have been isolated from
this plant. Ethanolic extract of R. japonica showed an estrogenic RP
(3.28 × 10–3) (Zhang et al., 2005).
Turnera diffusa Willd. Ex Schult.
This plant, known as damiana, oreganillo, or Mexican tea,
grows in Bolivia, Brazil, Mexico, and North America. The
leaves of T. diffusa contain the monoterpenes 1,8-cineole,
p-cymene, alpha and beta-pinene, tetrafilin B, and caffeine. In
the branches, also it has the flavonoid gonzalistosin, steroid
beta-sitosterol, and the xacosanol alkanes n-triacontane and
tricosan-2-one. The extracts of T. diffusa show antibacterial
and antioxidant properties (Soriano-Melgar Lde et al., 2014).
Methanolic extract demonstrated a dose-dependent
inhibitory effect on aromatase activity (IC50  63.1 mg/ml).
From 24 compounds tested, pinocembrin and acacetin were
the most potent aromatase inhibitors having IC50 values of
10.8 and 18.7 mM, respectively. In addition, three
compounds from the extracts apigenin 7-glucoside,
Z-echinacin, and pinocembrin showed EA (Zhao et al.,
2008). Previous studies have shown that T. diffusa has
components such as arbutin that inhibit lipid peroxidation
and has immunomodulatory and anti-oxidant properties that
have proven beneficial for stomach ulcers (Taha et al., 2012).
Anti-inflammatory activity has been found for leaf extracts of
Turnera subulata found in the Northeastern regions of Brazil
(Souza et al., 2016).
Cullen corylifolium (L.) Medik.
In the TCM, Cullen corylifolium (L.) Medik. (Fabaceae) is also
known as Buguzhi, and is used to reduce inflammatory
processes. The study of ethanolic extracts of C.
corylifolium, revealed a estrogenic RP of (1.90 × 10–4)
(Zhang et al., 2005). The ethanolic extracts of C.
corylifolium contained bakuchiol, psoralen,
isobavachalcone, isobavachromene, and bavachinin. Also,
hexane and chloroform extracts showed EA when tested in
a yeast estrogen screen assay. In this assay, ethanol, hexane,
chloroform extracts of CC showed EA, and bakuchiol showed
similar EA than genistein (10–6 M). In an ER binding assay,
bakuchiol displayed the strongest ER-binding affinity and
five times higher affinity for ERα than for ERβ (Lim et al.,
2011).
Psoralen is the main bioactive compound in the fruits of C.
corylifolium. It is used to treat inflammation, bacterial
infections (destroying the formation of biofilm), viral
infections, and conditions associated with menopause such
as osteoporosis (Ren et al., 2020). Psoralen’s anti-osteoporotic
effect involve different proteins factors that participate in the
bone remodeling such as bone morphogenetic proteins
(BMPs), matrix metalloproteinases, peroxisome
proliferators-activated receptor-gamma (PPARgamma), as
well as signaling cascades including the inositol-requiring
enzyme 1 (IRE1)/apoptosis signaling kinase 1 (ASK1)/c-jun
N-terminal kinase (JNK), wnt/β-catenin, and the Protein
kinase B (Akt)/activator protein-1 (AP-1) pathways (Ren
et al., 2020). These signaling factors may help to treat
osteoporosis by activating the osteoblast/osteoclast/
chondrocyte differentiation process. The anti-inflammatory
and neuroprotective effects of psoralen seem to be the result of
its interaction with viral polymerase (Pol), and regulating the
activation of TNF-α, transforming growth factor β (TGF-β),
interleukin (IL) -4/5/6/8/12/13, GATA-3, and AChE (Ren
et al., 2020).
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Curcuma aromatica Salisb.
Curcuma aromatica Salisb. (Zingiberaceae) also known as wild
turmeric. An early study found EA in rhizome extracts of this
plant with RP of 8.5 × 10–4 (Kang et al., 2006). Another study
investigated the putative estrogenic and/or antiestrogenic
activities of several Asiatic medicinal plants. They found that
the highest EA (relative to 17 β -estradiol, RP  1) were in this
order: flowers extracts of Pueraria lobata (RP, 7.75 × 10–3),
Amomum xanthioides (1.25 × 10–3), Glycyrrhiza uralensis,
Zingiber officinale, Rheum undulatum, Curcuma aromatica,
Eriobotrya japonica, Sophora flavescens, Anemarrhena
asphodeloides, Polygonum multiflorum, and Pueraria lobata
roots (ranging from 9.5 × 10–4 to 1.0 × 10–4). Prunus persica,
Lycoppus lucidus, and Adenophora stricta had lower RP (9.0 ×
1 0–5 to 8.0 × 10–5). Cinnamomum cassia and Prunus persica,
showed antiestrogenic effects with RP of 1.14 × 10–3 and 7.4 ×
10–4, respectively (tamoxifen RP  1) (Kim et al., 2008).
In addition, Curcuminoids from C. aromatica have
neuroprotective activities against oxidative stress.
Curcuminoids present in the radix of C. aromatica are
neuroprotective against the toxic effects of 24 h-treatment with
H2O2 in PC12 cells. The curcumoids increased cell survival,
decreased the release of LDH (a measure of cell death), the
cellular Ca2+, and ROS levels, enhanced the activities of
antioxidant proteins such as SOD, catalase (CAT) and GSH,
stabilized the mitochondrial membrane potential, and improved
PC12 morphology. The chemical analysis showed that
diarylheptanoids and sesquiterpenoids are the primary active
chemicals in the extracts tested. On the other hand, Curcumin
is the main component of Curcuma longa, a Chinese medicinal
plant used to alleviate brain disorders, which is neuroprotective
and increases the survival of cultured rodent cortical neurons.
The protective effects of curcumin were blocked when neurons
were pretreated with a tyrosine kinase B (TrkB) antibody, known
to inhibit the activity of the brain-derived neurotrophic factor
(BDNF). Conversely, treatment with curcumin increased BDNF
and phospho-TrkB effects that, in turn, were blocked by ERK and
PI3K inhibitors. Curcumin activated ERK, CREB, and AKT, by
mechanisms involving MAPK and PI3K. The authors concluded
that curcumin beneficial effects might be mediated via the BDNF/
TrkB-MAPK/PI-3K-CREB pathway (Wang et al., 2010).
Eriobotrya japonica (Thunb.) Lindl
Eriobotrya japonica (Thunb.) Lindl. (Rosaceae) commonly
known as the Japanese Medlar or loquat. A study reported
that methanolic extracts of E. japonica induced an increase
of EA (>50%) (Kang et al., 2006). Ethyl acetate fractions of E.
japonica showed EA with an RP of 6.1 × 10–2 (RP E2  1.0) (Kim
et al., 2008). However, it my be used with caution as seeds, or
pips, and young leaves are slightly poisonous because contain
little amounts of cyanogenic glycosides such as amygdalin
which release cyanide if eaten. However, numerous studies
have shown powerful anti-inflammatory effects in different
disease conditions. Silver nanoparticles of Eriobotrya
japonica AgNPs stimulated phagocytosis and prevent
allergies and the authors concluded that E. japonica could be
a promising therapy for preventing inflammation, and bacterial
infection by enhancing of phagocytosis (Jabir et al., 2021),
arthritis (Kuraoka-Oliveira et al., 2020), asthma (Kim T.-M.
et al., 2020), intestinal problems, hepatic damage induced by
acetaminophen (Jiang et al., 2017), and metabolic syndrome
induced by a high fat diet in C57BL/6J mice (Li F. et al., 2020). In
the most recent study male mice 7–9 weeks of age were
randomly divided into three groups (n  6 mice/group). The
first treatment group received 250 µl of saline by IP injection,
the second received 50 µg LPS via IP and group 3 was pre-
treated with AgNPs (1mg/kg) and then received 50 µg LPS.
After 10 h, mice were sacrificed, and blood and peritoneal fluid
was taken for analysis of IL-1β and IL-6 levels. The results
showed that the AgNPs synthesized using E. japonica leaf
extract inhibited the LPS-induced synthesis and the levels of
cytokines such as IL-1β and IL-6 (Jabir et al., 2021).
Vigna radiata (L.) R.Wilczek
Vigna radiata (L.) R.Wilczek (Fabaceae) is known as mung bean
sprout, common in the tropics and warm temperature zones and
its extracts have shown to increase cell proliferation above the
levels induced by estradiol. This proliferation was suppressed by
the ER antagonist, ICI 182.780, suggesting that ER signaling
pathways are mediating the proliferative effects of V. radiata
(Boue et al., 2003).
Preclinical studies have investigated anti-inflammatory and
antiarthritic activity of V. radiata sprouts in rats. Ethanolic
extracts of the sprouts were used to evaluate its antiarthritic
activity using rats treated with complete Freund’s adjuvant as a
model of arthritis. Treatment with ethanolic extracts ofV. radiata
significantly reduced the biochemical changes induced by the
Freund’s adjuvant, such as lipid peroxidation, total reduced
glutathione, myeloperoxidase and lysosomal enzymes like
cathepsin-D, N-acetyl beta-D-glucosaminase and beta-D-
glucuronidase. The findings of this study suggest that V.
radiata can reduce inflammation in arthritis (Venkateshwarlu
et al., 2016). Further studies are required to investigate its effects
in other inflammatory conditions.
Wurfbainia villosa var. Xanthioides (Wall. ex
Baker) Skornick. and A.D.Poulsen
Wurfbainia villosa var. Xanthioides (Wall. ex Baker) Skornick.
and A.D.Poulsen, commonly known as bastard cardamom and
Malabar Cardamom, is a medicinal plant native to Indonesia that
is used to treat spleen and stomach diseases in China (An et al.,
2020). Butanolic fractions of W. villosa var. xanthioides showed
EA with a relative potency of 6.6 × 10–2 (RP of E2  1.0) (Kim
et al., 2008). Also, methanolic extract of this plant effectively
induced a 50% increase in EA (Kang et al., 2006).
The herbal mix named CG (plus) contains Artemisia gmelinii
Weber ex Stechm. (syn, Artemisia iwayomogi Kitamura), W.
villosa and Salvia miltiorrhiza Bunge. The effect of CG (plus)
on stress for immobilization (IS) was recently assessed in mice.
Male BALB/c mice were daily treated with different doses of
aqueous extracts of CG (plus) (0–200 mg/kg) for 5 days. On the
last day, mice were subjected to IS for 6 h. Stress increased
corticosterone levels, adrenaline, cytokines, and the enzyme
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markers of hepatic injury (ALT and AST) in serum. The mix CG
(plus) significantly prevented the effects of stress (Kim H.-G.
et al., 2020).
Iris domestica (L.) Goldblatt & Mabb.
Iris domestica (L.) Goldblatt & Mabb. syn Belamcanda chinensis
(Iridaceae) commonly known as Blackberry Lilly. The ethanolic
extract of I. domestica showed EA with a RP of (1.26 × 10–4)
(Zhang et al., 2005). Isoflavonoids obtained from a methanolic
extract of I. domestica rhizomes inhibited mutagenesis when
tested in the Ames test and have antioxidant effects. The
isoflavonoids reduced transition-metal ions and prevented the
peroxidation of polyunsaturated fatty acids. The isoflavones,
identified included the glycosides tectoridin and iridin and the
aglycones irigenin, tectorigenin, and 5,6,7,3′-tetrahydroxy-4′-
methoxyisoflavone (Wozniak et al., 2010).
Senna obtusifolia (L.) H.S.Irwin and Barneby
Senna obtusifolia (L.) H.S.Irwin and Barneby (syn. Cassia
obtusifolia L.) (Fabaceae) is commonly known as American
sicklepod. S. obtusifolia is a weed that grows in the world’s
tropical and subtropical regions, even when the environmental
conditions are unfavorable. This plant has been investigated as a
laxative and sexual stimulant in male rats (Ajayi et al., 2014).
Ethanolic extracts of S. obtusifolia have shown estrogenic RP of
3.49 × 10–4 (Zhang et al., 2005). However, its toxic effects
observed in cattle and mice discouraged its use as a medicinal
plant (Furlan et al., 2014; Ana Maria et al., 2019).
A different study investigated the effects of Aurantio-obtusin,
an anthraquinone isolated from dried seeds of S. obtusifolia and
Cassia tora L. (syn. Senna tora). Aurantio-obtusin was tested as
an anti-inflammatory compound on lipopolysaccharide- (LPS)-
induced inflammation in RAW264.7 cells. ELISA and
quantitative real-time PCR (qRT-PCR) assays revealed that
this compound significantly decreased the production of NO
and PGE2 by inhibiting the expression of COX-2 and iNOS, as
well as the cytokines TNF-α, and IL-6. Aurantio-obtusin showed
anti-inflammatory effects via the inhibition of NFκB in
RAW264.7 cells. These results suggested that this compound
could have therapeutic value against inflammatory diseases.
Medicago sativa L.
Medicago sativa L. (Fabaceae) is commonly known as alfalfa
sprout. M. sativa extracts induce more cell proliferative
effects than estradiol. The estrogen receptor antagonist ICI
182,780 (Fulvestrant) suppressed the cell proliferation
induced by the extracts, suggesting that ERs were involved
(Boue et al., 2003). Moreover, the phytoestrogens present in
these extracts exhibited selectivity toward ERβ (Boue et al.,
2003). Also a recent study showed that Alfalfa extracts have
dose-dependent beneficial effect on nicotine-induced
oxidative damage and neuroinflammation in the brain as
well as reducing anxiety (Raeeszadeh et al., 2021). In this
study the authors investigated the effect of the hydroalcoholic
extract of M. sativa on brain damage and anxiety behavior in
male Wistar rats exposed to nicotine. Rats were randomly
divided into six treatment (T) groups: T1 and T2 were
subcutaneously injected with 250 and 500 mg/kg alfalfa
extract, respectively, T3 and T4 groups where animals
were injected subcutaneously with 0.2 mg/kg nicotine and
250 and 500 mg/kg alfalfa extract, and T5 group was injected
with 0.2 mg/kg nicotine. After treatments, the serum levels of
the cytokines TCA, IL-1, and TNFα and oxidative stress-
defensive factors such as gluthation (GPx, SOD, total
antioxidant capacity (TAC), and MDA) in the brain were
assayed. The time and number of entrances in the open arm
significantly decreased in the treated groups in a dose-
depended manner. Oxidative stress parameters were higher
in the nicotine -treated rats and lower in the rats treated with
500 mg/kg alfalfa extracts (T2). Nicotine increased the levels
of the cytokines TNFα and IL-1 in the T5 group when
compared to the other groups. More importantly,
treatment with the alfalfa extracts increased the levels of
the antioxidant factors GPx and SOD and decreased the
number of necrotic neurons and gliosis in the nicotine-
treated rats (Raeeszadeh et al., 2021).
Phaseolus vulgaris L.
Phaseolus vulgaris L.(Fabaceae) is also known as green bean or
red kidney bean (Boue et al., 2011; de Lima et al., 2014). P.
vulgaris produces phytoalexins (isoflavones) under stress
conditions such as wounding and/or insect damage. Thus to
induce the expression of flavonoids, the components of
methanolic extracts of red kidney bean that were treated with
the fungus Aspergillus sojae, and untreated controls plants were
tested for estrogenic activity using an ERE luciferase reporter
assay (Boue et al., 2011). The estrogenic activities of the
phytoalexins kievitone and phaseollin were isolated from
fungus-treated red kidney bean extracts and analyzed for EA
using ERα and ERβ binding and ERE luciferase and cell
proliferation assays in MCF-7 and HEK 293 cells. These
phytoalexins stimulated MCF-7 cell proliferation and
Kievitone showed a higher binding affinity to ERα and
Phaseollin to ERβ. Although phaseollin displayed attenuation
of ER transactivation in the ERE luciferase assay in MCF-7 cells,
both phytoalexins attenuated the effects of E2 in an MCF-7 cell
survival assay showing estrogenic and antiestrogenic activities
(Boue et al., 2011). The green bean extracts were more effective in
inducing cell proliferation than estradiol and exhibited a
preferential affinity for ERβ. The proliferative effects were due
to its estrogenic effects as it was suppressed by ICI 182,780 (Boue
et al., 2011). P. vulgaris has shown antioxidant activity in both cell
and animal studies (Venkateswaran et al., 2002; Venkateswaran
and Pari, 2002; Ampofo and Ngadi, 2020). One recent study,
investigated phenolic compounds, and antioxidant activity, of
different species of the genus Phaseolus. The species closest to
each other in terms of essential amino acid content were P.
polyanthus with P. vulgaris and P. lunatus with P. coccineus.
Previous studies show a positive correlation between antioxidant
activity and flavonoids, anthocyanins, and lectins. Significant
differences in the content of phenolic compounds have been
found among the bean species. No obstant, in addition to P.
vulgaris, other species such as P. coccineus and P. lunatus have
high antioxidant potential (Alcazar-Valle et al., 2020).
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Pueraria montana var. lobata (Willd.)
Maesen and S.M.Almeida ex Sanjappa and
Predeep
Pueraria montana var. lobata (Willd.) Maesen and S.M.Almeida
ex Sanjappa and Predeep (Fabaceae), also known as kudzu, is a
perennial leguminous vine used as an herbal medicine in Asia,
containing flavonoids that are concentrated in its root (Eom et al.,
2018). Methanolic extract of flowers of P. lobata increased the EA
> 50%, but roots only showed moderate EA (Kang et al., 2006).
Extracts of kudzu roots induced cell proliferation by a mechanism
involving ER as it was suppressed by the antagonist, ICI 182,780
(Boue et al., 2003). Ethanolic extracts of Pueraria lobata showed
an estrogenic RP of (6.17 × 10–5) (Zhang et al., 2005). In another
study, 17β-estradiol showed EA with an EC50  0.205 ± 0.025 ng/
ml (RP  100) and methanolic extracts of flowers and stem of P.
montana var. lobata showed EA with EC50 values of 8.6–1.0 μg/
ml, respectively (Yoo et al., 2005).
A study that used peritoneal macrophages isolated from BALB/
c mice and cells activation with lipopolysaccharide (LPS) or LPS
plus interferon (IFN)-gamma revealed that kudzu leaf and its
principal active compound robinin (kaempferol-3-O-robinoside-
7-O-rhanmoside) have anti-inflammatory activity. The extract
inhibited the macrophage synthesis of the inflammatory factors
iNOS, COX-2, TNFα, and IL-6. Kudzu extracts decreased LPS-
induced activation of (JNK and TANK-binding kinase 1 (TBK1).
Also, kudzu extract inhibited LPS/IFN-gamma-induced expression
of the signal transducer and activator of transcription 1 (STAT1).
Robinin decreased iNOS protein involving modulation of JNK and
STAT1 activation. But without any impact on other inflammatory
markers such as NFκB (Eom et al., 2018).
OTHER ESTROGENIC PLANTS
Many other plants with demonstrated EA require further
characterization include: Adenophora stricta Miq.
(Campanulaceae), native to East Asia (China), also known as
Sha Shen and Ladybells (Kim et al., 2008); Artemisia vulgaris L.
(Asteraceae), often named mugwort, contains the flavonoids
eriodictyol and apigenin (Lee et al., 1998); Asplenium
trichomanes L. (Aspleniaceae) known as maidenhair spleenwort,
it is used to control irregular menses and as an emmenagogue,
aborticide, expectorant, anti-cough remedy, and laxative
(Dall’Acqua et al., 2009); Hylodesmum podocarpum subsp.
oxyphyllum (DC) H. Ohashi and R.R.Mill. syn. Desmodium
oxyphyllum (Fabaceae). This plant, also called ticktrefoils, is a
medicinal plant from Asia, that is used for breast cancer (Yoo
et al., 2005); Maackia amurensis-Rupr (Fabaceae), is a tree also
known as Amur maackia (Yoo et al., 2005; Grishchenko et al.,
2016); Humulus lupulus L. (Cannabaceae) Methanolic plant
extracts bind to ERα and ERβ. And it has EA. Numerous
studies of the estrogenic properties for hops are attributed to
the component 8-prenylnarigenin (Liu et al., 2001). Another
study compared the estrogenic effects of hops to other plants of
the licorice species (Glycyrrhiza glabra,G. inflata, and G. uralensis)
(Hajirahimkhan et al., 2013). All extracts showed EA when tested
in cultured endometrial cancer cells, MCF-7 cells expressing an
ERE directing the expression of the fluorescent reporter luciferase.
The authors ordered the plant extracts by decremental EA as
follows: H. lupulus > G. uralensis > G. inflata > G. glabra.
Liquiritigenin was selective for ERβ, and isoliquiritigenin was
equipotent for both ERα/β. 8-Prenylnaringenin showed
nanomolar estrogenic RP without ER selectivity (Hajirahimkhan
et al., 2013). A recent study identified 8-Prenylapigenin from
Glycyrrhiza inflata as an ERβ agonist (Hajirahimkhan et al., 2018).
CONCLUSIONS AND FUTURE
PERSPECTIVE
The deficit of estrogen is involved in the development or
progression of various types of autoimmune diseases, cancer
(breast, colorectal, endometrium, ovary, prostate), cardiovascular
diseases, osteoporosis, obesity, insulin resistance, and
neurodegenerative diseases and mood disorders. The deficit in
sex hormones such as estrogen negatively impacts the cognitive
abilities, general health, and consequently the quality of life of
millions of persons around the world. HRT positively impacts
cognitive abilities and immune function, but its benefits seem to be
restricted to the early stages of menopause. After menopause, HRT
with estrogens combined with progestins has shown beneficial
effects on climacteric symptoms and osteoporosis in the bone and
on body weight. However, it increases the risk of mammary
carcinomas and cardiovascular diseases. Consequently, plant-
derived alternatives are currently investigated. The advancement
of our understanding of the molecular mechanisms underlying the
effects of plant-derived estrogenic compounds will facilitate the
discovery of new therapies to counteract the adverse effects of a
deficit of estrogen in the brain. Interestingly, many plants used in
traditional medicine have shown estrogenic activity that is
concurrent with antioxidant, antiproliferative, and anti-
inflammatory activities.
The discovery of estrogenic compounds frommedicinal plants
with lower side effects should permit to improve the cognitive
abilities in women affected by menopause and other conditions
inducing oxidative stress and neurodegeneration without the side
effects elicited by actual HRT.
Recently encouraging clinical results with a combination of
herbs have shown to be effective and safe in decreasing
menopause symptoms (Rattanatantikul et al., 2020). Also,
phytoestrogens and their metabolites from medicinal plants
have been shown to mimic the benefits of endogenous
estrogens, and estrogen-based therapies are considered
promising approaches for preventing the onset and
progression of neurodegenerative disorders (Bustamante-
Barrientos et al., 2021). Though, xenoestrogens derived from
plastic polycarbonates, such as water bottles and varnish
coating in food cans, can alter estrogen-mediated signaling
pathways inducing a negative effect on health. It may be
required to counteract the estrogen deficit in a more holistic
approach comprising an adequate diet containing natural
estrogenic compounds, body and mental exercise practices
that promote neurogenesis, a more ecologically friendly way
of life, and adequate social and spiritual support systems to
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decrease the effects of stress. On the other hand, the explosive
development of new genetic therapies may permit the
modulation of specific estrogenic receptors in the brain,
bones, and other tissues without increasing the risk of
disease while preventing the pathological effects of lower
sex hormones’ levels.
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GLOSSARY
AAB Anemarrhena asphodeloides Bunge
Aβ Amyloid beta petide
AChEI acetylcholinesterase inhibitors
AD Alzheimer’s disease
AGE advanced glycation endproducts
APOE Apolipoprotein E
APP Aβ precursor protein
AR androgen receptor
BDNF brain-derived neurotrophic factor
BMD bone mineral density




CRE cAMP response element





GFAP glial fibrillar acidic protein
GQD Gegen Qinlian Decoction
GSH reduced glutathione
GST glutathione S-transferase activity
hER human ER





MMSE Mini-Mental State Examination
MS multiple sclerosi
NFκB nuclear factor kappa B
NO nitric oxide
NOS nitric oxide synthase
OVX ovariectomized
PKA protein kinase A
PKB protein kinase B
PKC protein kinase C
PS1 presenilin 1
PR progesterone receptor
QOL quality of life
RP relative potency
SHBG sex hormone binding globulin
Tg transgenic
TNF-α tumor necrosis factor alpha
YCJ young coconut juice
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